Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses-Reference-Cited by-同舟云学术

Lenalidomide enhances the function of chimeric antigen receptor T cells against the epidermal growth factor receptor variant III by enhancing immune synapses

Published:2015-10 Issue:10 Volume:22 Page:487-495
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Kuramitsu S,Ohno M,Ohka F,Shiina S,Yamamichi A,Kato A,Tanahashi K,Motomura K,Kondo G,Kurimoto M,Senga T,Wakabayashi T,Natsume A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/cgt201547.pdf

Reference45 articles.

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987–996.

2. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459–466.

3. Rosenberg SA . Progress in human tumour immunology and immunotherapy. Nature 2001; 411: 380–384.

4. Johnson LA, Sampson JH . Immunotherapy approaches for malignant glioma from 2007 to 2009. Curr Neurol Neurosci Rep 2010; 10: 259–266.

5. Chung DS, Shin HJ, Hong YK . A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy. J Immunol Res 2014; 2014: 326545.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors;Med;2024-06

2. Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy;HemaSphere;2024-05

3. Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma;Cellular and Molecular Biology;2024-02-29

4. Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7;Leukemia;2023-12-20

5. Lenalidomide improves NKG2D-based CAR-T cell activity against colorectal cancer cells invitro;Heliyon;2023-10